國立虎尾科技大學 |

Encyclopedia of Psychopharmacology

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Encyclopedia of Psychopharmacology/ edited by Ian P. Stolerman, Lawrence H. Price.
其他作者:	Price, Lawrence H.
面頁冊數:	XLVI, 690 p. 206 illus., 80 illus. in color.online resource. :
Contained By:	Springer Nature Living Reference
標題:	Biomedicine, general. -
電子資源:	https://doi.org/10.1007/978-3-642-27772-6
ISBN:	9783642277726

Encyclopedia of Psychopharmacology
Encyclopedia of Psychopharmacology[electronic resource] /edited by Ian P. Stolerman, Lawrence H. Price. - XLVI, 690 p. 206 illus., 80 illus. in color.online resource.

From the Contents: ABC Transporters -- Absorption -- Abstinence -- Abuse -- Abuse Liability -- Acamprosate -- BAC -- Balanced Placebo Design -- Barbital -- Barbiturates -- Basal Forebrain Cholinergic Neurons -- Behavioral Allocation Function -- Cabergoline -- Cachexia -- Caffeine -- Caffeine Withdrawal Syndrome -- Caffeinism -- cAMP -- DARPP-32 -- db/db Mouse -- D-cycloserine -- Decision Making -- Declarative and Non-Declarative Memory -- Declarative Memory -- Early Ventral Hippocampal Lesion Model -- Eating and Appetite -- Eating Disorder: Anorexia Nervosa -- Eating Disorders: Animal Models -- Eating Disorders: Binge-Eating -- Echolalia -- FAA -- Face Validity -- Facial Dysmorphology -- False Memory -- False Negative -- False Positive -- G protein-Coupled Receptors -- GABA -- GABAA Receptor -- GABAergic Transmission -- Gabapentin -- Galantamine -- Habit Reversal Therapy -- Habit Reversal Training -- Habituation -- Half-Life -- Hallucinations -- Hallucinogen Abuse -- IACUC -- ICD -- Idiopathic -- Imaging Mass Spectrometry -- Imipramine -- Impairment of Functioning; Measurement Scales -- Kappa-Opioid Agonists -- Kappa-Receptor -- Keratotic Lesion -- Ketamine -- Ketamine -- Khat -- L-Alpha-Acetyl-Methadol -- Lamotrigine -- Lanreotide -- Latent Inhibition -- Latin Square Design -- Laxatives -- Magnetic Resonance Imaging -- Major and Minor and Mixed Anxiety-Depressive Disorders -- Major Tranquilizer -- Mania -- MAO-B Inhibitor -- Mass Spectrometry -- N-Acetylcysteine -- Nafion -- Naloxone -- Naltrexone -- N-Arachidonylethanolamine -- Narcolepsy -- ob/ob Mouse -- Obsessions -- Obsessive-Compulsive Anxiety Disorders -- Occasion Setting with Drugs -- Octreotide -- Off-Label Use of Drugs -- P300 -- Pain -- Pain and Psychopharmacology -- Pair-Feeding -- Palatability -- Paliperidone -- qEEG -- QT Interval -- Quality of Life -- Quazepam -- Quetiapine -- Radial Arm Maze -- Radionuclide -- Radiopharmaceutical -- Radiotracer -- Randomized Controlled Trials -- Rapamycin -- Saporin -- Satiety -- Saturation Binding Curve -- Scalar Property -- Schedule I -- Schedule II -- Tachykinins -- Tachyphylaxis -- Tandospirone -- Tardive Dyskinesia -- Taste Reactivity Test -- Temazepam -- Ubiquitin-Proteasome System -- Ultrasonic -- Ultrasonic Vocalizations -- Ultrasonic Vocalizations -- Unblocking -- Unconditional Response -- Vaccination -- Vaccines and Drug-Specific Antibodies -- Vagus Nerve Stimulation -- Valproic Acid -- Values-Based Medicine -- Varenicline -- Wakefulness -- Water Maze -- Whole-Cell Recording -- Wisconsin Card Sorting Test -- Wisconsin General Test Apparatus -- Withdrawal Syndromes -- Yale-Brown Obsessive-Compulsive Scale -- Yohimbine -- Zaleplon -- Zero-Order Elimination Kinetics -- Ziprasidone -- Zolpidem -- Zonisamide -- Zopiclone.

Psychopharmacology is the study of the effects of psychoactive drugs on the functioning of the central nervous system at all levels of analysis, thus embracing cognition, behaviour, psychological states, neurophysiology, neurochemistry, gene expression and molecular biology. It includes, as an integral part of its domain, the interaction of environmental and genetic factors with psychoactive drug action, their medicinal and social uses, and their abuse. The Encyclopedia of Psychopharmacology provides detailed information on psychopharmacology and its sub-disciplines, such as clinical psychopharmacology, molecular neuropsychopharmacology, behavioural pharmacology in laboratory animals, preclinical psychopharmacology, human experimental psychopharmacology. The wide-ranging entries in the Encyclopedia of Psychopharmacology are written by leading experts. They will provide basic and clinical scientists in academia as well as industry with valuable information about the field of psychopharmacology. Also people in related fields, students, teachers, and interested laypeople will benefit from the important and relevant information on the most recent developments of psychopharmacology. Entries will fall into several main categories: Methods, techniques and target systems (explaining nature of a technique and its uses and limitations) - Drugs and classes of drug (mainly describing effects and mechanisms of action) - Psychiatric states (explaining drugs used to treat them) - Miscellaneous currently interesting topics that do not fall within the above (e.g. cognitive enhancement, regulation and licensing, substance use in religious rituals).

ISBN: 9783642277726

Standard No.: 10.1007/978-3-642-27772-6doiSubjects--Topical Terms:

1253757
Biomedicine, general.

LC Class. No.: RM1-950

Dewey Class. No.: 615

Encyclopedia of Psychopharmacology
LDR:05688nam a22003615i 4500 001 1026711
003 DE-He213
005 20200702065322.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783642277726 $9 978-3-642-27772-6
024 7 $a 10.1007/978-3-642-27772-6 $2 doi
035 $a 978-3-642-27772-6
050 4 $a RM1-950
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615 $2 23
245 1 0 $a Encyclopedia of Psychopharmacology $h [electronic resource] / $c edited by Ian P. Stolerman, Lawrence H. Price.
264 1 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2020.
300 $a XLVI, 690 p. 206 illus., 80 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a From the Contents: ABC Transporters -- Absorption -- Abstinence -- Abuse -- Abuse Liability -- Acamprosate -- BAC -- Balanced Placebo Design -- Barbital -- Barbiturates -- Basal Forebrain Cholinergic Neurons -- Behavioral Allocation Function -- Cabergoline -- Cachexia -- Caffeine -- Caffeine Withdrawal Syndrome -- Caffeinism -- cAMP -- DARPP-32 -- db/db Mouse -- D-cycloserine -- Decision Making -- Declarative and Non-Declarative Memory -- Declarative Memory -- Early Ventral Hippocampal Lesion Model -- Eating and Appetite -- Eating Disorder: Anorexia Nervosa -- Eating Disorders: Animal Models -- Eating Disorders: Binge-Eating -- Echolalia -- FAA -- Face Validity -- Facial Dysmorphology -- False Memory -- False Negative -- False Positive -- G protein-Coupled Receptors -- GABA -- GABAA Receptor -- GABAergic Transmission -- Gabapentin -- Galantamine -- Habit Reversal Therapy -- Habit Reversal Training -- Habituation -- Half-Life -- Hallucinations -- Hallucinogen Abuse -- IACUC -- ICD -- Idiopathic -- Imaging Mass Spectrometry -- Imipramine -- Impairment of Functioning; Measurement Scales -- Kappa-Opioid Agonists -- Kappa-Receptor -- Keratotic Lesion -- Ketamine -- Ketamine -- Khat -- L-Alpha-Acetyl-Methadol -- Lamotrigine -- Lanreotide -- Latent Inhibition -- Latin Square Design -- Laxatives -- Magnetic Resonance Imaging -- Major and Minor and Mixed Anxiety-Depressive Disorders -- Major Tranquilizer -- Mania -- MAO-B Inhibitor -- Mass Spectrometry -- N-Acetylcysteine -- Nafion -- Naloxone -- Naltrexone -- N-Arachidonylethanolamine -- Narcolepsy -- ob/ob Mouse -- Obsessions -- Obsessive-Compulsive Anxiety Disorders -- Occasion Setting with Drugs -- Octreotide -- Off-Label Use of Drugs -- P300 -- Pain -- Pain and Psychopharmacology -- Pair-Feeding -- Palatability -- Paliperidone -- qEEG -- QT Interval -- Quality of Life -- Quazepam -- Quetiapine -- Radial Arm Maze -- Radionuclide -- Radiopharmaceutical -- Radiotracer -- Randomized Controlled Trials -- Rapamycin -- Saporin -- Satiety -- Saturation Binding Curve -- Scalar Property -- Schedule I -- Schedule II -- Tachykinins -- Tachyphylaxis -- Tandospirone -- Tardive Dyskinesia -- Taste Reactivity Test -- Temazepam -- Ubiquitin-Proteasome System -- Ultrasonic -- Ultrasonic Vocalizations -- Ultrasonic Vocalizations -- Unblocking -- Unconditional Response -- Vaccination -- Vaccines and Drug-Specific Antibodies -- Vagus Nerve Stimulation -- Valproic Acid -- Values-Based Medicine -- Varenicline -- Wakefulness -- Water Maze -- Whole-Cell Recording -- Wisconsin Card Sorting Test -- Wisconsin General Test Apparatus -- Withdrawal Syndromes -- Yale-Brown Obsessive-Compulsive Scale -- Yohimbine -- Zaleplon -- Zero-Order Elimination Kinetics -- Ziprasidone -- Zolpidem -- Zonisamide -- Zopiclone.
520 $a Psychopharmacology is the study of the effects of psychoactive drugs on the functioning of the central nervous system at all levels of analysis, thus embracing cognition, behaviour, psychological states, neurophysiology, neurochemistry, gene expression and molecular biology. It includes, as an integral part of its domain, the interaction of environmental and genetic factors with psychoactive drug action, their medicinal and social uses, and their abuse. The Encyclopedia of Psychopharmacology provides detailed information on psychopharmacology and its sub-disciplines, such as clinical psychopharmacology, molecular neuropsychopharmacology, behavioural pharmacology in laboratory animals, preclinical psychopharmacology, human experimental psychopharmacology. The wide-ranging entries in the Encyclopedia of Psychopharmacology are written by leading experts. They will provide basic and clinical scientists in academia as well as industry with valuable information about the field of psychopharmacology. Also people in related fields, students, teachers, and interested laypeople will benefit from the important and relevant information on the most recent developments of psychopharmacology. Entries will fall into several main categories: Methods, techniques and target systems (explaining nature of a technique and its uses and limitations) - Drugs and classes of drug (mainly describing effects and mechanisms of action) - Psychiatric states (explaining drugs used to treat them) - Miscellaneous currently interesting topics that do not fall within the above (e.g. cognitive enhancement, regulation and licensing, substance use in religious rituals).
650 2 4 $a Biomedicine, general. $3 1253757
650 2 4 $a Molecular Medicine. $3 668353
650 1 4 $a Pharmacology/Toxicology. $3 593882
650 0 $a Medicine. $3 644133
650 0 $a Molecular biology. $3 583443
650 0 $a Pharmacology. $3 583819
700 1 $a Price, Lawrence H. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1323042
700 1 $a Stolerman, Ian P. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1257425
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature Living Reference
856 4 0 $u https://doi.org/10.1007/978-3-642-27772-6
912 $a ZDB-2-SBL
912 $a ZDB-2-SXRB
912 $a ZDB-2-SLR
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Reference Module Biomedical and Life Sciences (SpringerNature-43744)